Emerald Advisers’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-100,844	Closed	-$4.64M	–	247
2017 Q2	$4.64M	Sell	100,844 -205,026	-67%	-$9.94M	0.19%	114
2017 Q1	$13.2M	Sell	305,870 -8,777	-3%	-$376K	0.54%	74
2016 Q4	$12.2M	Buy	314,647 +57,818	+23%	+$2.62M	0.52%	78
2016 Q3	$13M	Buy	256,829 +8,710	+4%	+$434K	0.58%	66
2016 Q2	$11.3M	Sell	248,119 -65,425	-21%	-$3.01M	0.54%	63
2016 Q1	$12.4M	Buy	313,544 +10,337	+3%	+$410K	0.6%	62
2015 Q4	$17.2M	Buy	303,207 +36,180	+14%	+$1.84M	0.81%	32
2015 Q3	$10.6M	Sell	267,027 -198,419	-43%	-$9.59M	0.55%	61
2015 Q2	$22.2M	Buy	465,446 +3,193	+0.7%	+$135K	1.06%	19
2015 Q1	$17.5M	Sell	462,253 -78,720	-15%	-$2.82M	0.88%	26
2014 Q4	$12.1M	Buy	540,973 +206,790	+62%	+$3.92M	0.64%	47
2014 Q3	$5.24M	Buy	334,183 +94,193	+39%	+$1.41M	0.31%	105
2014 Q2	$3.56M	Buy	239,990 +1,580	+0.7%	+$22.3K	0.2%	154
2014 Q1	$3.84M	Buy	+238,410	New	+$4.08M	0.22%	143